Recent Finacing
Recent Raise
Caris Life Sciences provides whole-exome and whole-transcriptome sequencing, proteome analysis, and AI-driven analytics, plus blood-based cNAS assays and clinical-trial support to guide precision oncology decisions.
Focus Areas
Recent Investors
Valuation as of 05/11/2021
Total Raised
Funding rounds
Investors
See the team members at Caris Life Sciences.
